Edit
Alpine Immune Sciences, Inc.
https://www.alpineimmunesciences.com/Last activity: 10.03.2026
Active
Alpine Immune Sciences is a clinical stage biopharmaceutical company dedicated to discovering and developing innovative, protein-based immunotherapies targeting the immune synapse to treat cancer and autoimmune and inflammatory diseases. We have two products in the clinic for inflammatory diseases and cancer, collaborations with world-class partners, and a robust development pipeline. Traded on NASDAQ under ticker ALPN.
Location: United States, Washington, Seattle
Employees: 51-200
Total raised: $108M
Founded date: 2015
Investors 4
| Date | Name | Website |
| - | Omega Fund... | omegafunds... |
| - | RA Capital... | racap.com |
| - | OrbiMed | orbimed.co... |
| - | Frazier Li... | frazierls.... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 24.07.2020 | - | $60M | Omega Fund... |
| 13.06.2016 | Series A | $48M | OrbiMed |
Mentions in press and media 17
| Date | Title | Description |
| 10.03.2026 | Vertex passes key test in quest to treat kidney diseases | Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial. The drug, povetacicept, is a central piece of the company’s plan to expand into kidney disease. Vertex has faced questions about how it would div... |
| 01.08.2025 | Frazier Life Sciences: $1.3 Billion Venture Fund Closed | Frazier Life Sciences (FLS), an investment firm focused on innovative therapeutics, announced the closing of Frazier Life Sciences XII, L.P. (FLS XII), with over $1.3 billion in capital commitments. The oversubscribed fund received strong s... |
| 17.01.2025 | Innovent's Breakthrough in Pancreatic Cancer Treatment: A New Hope for Patients | In the relentless battle against pancreatic cancer, a new warrior has emerged. Innovent Biologics, a biopharmaceutical company, has received Breakthrough Therapy Designation (BTD) from China's National Medical Products Administration (NMPA)... |
| 16.01.2025 | Ouro Medicines: $120 Million Raised For Developing Immune Reset Therapeutics | Ouro Medicines, a biotechnology company creating immune reset therapeutics for people living with chronic immune-mediated diseases, announced its launch with $120 million in funding. And the company was launched by Monograph Capital in part... |
| 04.10.2024 | Frazier Life Sciences: Over $630 Million Added To Evergreen Public Fund | Frazier Life Sciences (FLS), a healthcare investment firm focused on innovative therapeutics, announced it has closed on over $630 million in capital commitments to its evergreen Public Fund from new and existing investors in an oversubscri... |
| 24.10.2022 | Alpine stops enrollment in cancer drug study after second patient death this year | A patient has died in a clinical trial testing an experimental Alpine Immune Sciences cancer immunotherapy, the second death in the study this year. The safety issue has prompted the company to stop enrollment in studies of the experimental... |
| 20.09.2022 | Alpine Immune Sciences Announces Pricing of $100 Million Public Offering | - |
| 15.09.2021 | Three Democrat reps oppose Medicare drug pricing plan; Alpine Immune announces private placement | A trio of key Democrats said yesterday they will oppose their party’s plan to lower drug prices — creating a substantial roadblock for the Democrats’ — and the White House’s — desired $3.5 trillion tax and spending package... |
| 24.05.2019 | Life sciences fund raises €118M for its next round of bets; Gilead scraps Alpine alliance | → A small but growing transatlantic biotech investor is getting a fresh shot in the arm for its next round of bets. Fountain Healthcare Partners has raised €118 million for Fund III, bringing its total amount of capital raised t... |
| 01.02.2019 | Seattle Venture Capital Watch: Alpine Immune, Wyze, Aduro, Gaia & More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Welcome to February! Whether your weekend plans involve watching the Super Bowl, tracking this year’s prediction by famed groundhog Punxsutawney Phil, or other activities, tak... |
Show more